Table 2.

Factors Predicting Medication Non-adherence and No-Show Visits

	Medication non-adherence	No-show visits
	OR (95% CI)	OR (95% CI)
No. Veterans	n = 2,076	n = 2,623
Age/years	.98 (.97–.99)	.99 (.98–1.00)
No. medications	.93 (.88–.99)	- -
No. visits	- -	1.11 (1.07–1.15)
No. unmet needs (ref = 0)
1 Needs	.98 (.75–1.28)	1.27 (1.01–1.59)
2 Need	1.09 (.78–1.52)	2.02 (1.49–2.75)
≥3 Needs	1.59 (1.19–2.13)	3.27 (2.43–4.39)
Female	.65 (.39–1.07)	.80 (.50–1.29)
Hispanic/Latino	2.61 (1.56–4.37)	1.52 (.94–2.47)
Race (ref = White)
Black	1.83 (1.31–2.54)	1.63 (1.17–2.26)
Other	1.73 (1.08–2.75)	1.25 (.81–1.94)
≤High school	1.04 (.83–1.29)	.98 (.81–1.19)
Priority group (ref = groups 6–8)
Group 1	.88 (.60–1.30)	1.85 (1.34–2.55)
Groups 2–3	1.19 (.79–1.80)	1.38 (.98–1.93)
Groups 4–5	1.19 (.81–1.76)	1.65 (1.19–2.28)
CCI comorbidity (ref = 0)
1	.94 (.70–1.27)	1.29 (1.00–1.65)
≥2	.99 (.75–1.30)	1.71 (1.37–2.15)
Region (ref = Northeast)
Continental	.80 (.58–1.09)	.88 (.67–1.15)
Pacific	1.10 (.79–1.53)	1.43 (1.05–1.94)
Southeast	.78 (.60–1.02)	1.44 (1.15–1.80)
Rural	1.05 (.86–1.29)	.89 (.74–1.07)

OR, odds ratio; CI, confidence interval for OR; CCI, Charlson Comorbidity Index